Showing 1641-1650 of 2652 results for "".
- Sifi Announces License Agreement with Avanzanite Bioscience for Acanthamoeba Keratitis Treatment Akantiorhttps://modernod.com/news/sifi-announces-license-agreement-with-avanzanite-bioscience-for-acanthamoeba-keratitis-treatment-akantior/2481340/Italy-based Sifi announced that it has partnered with Avanzanite Bioscience, a Dutch specialty pharmaceutical company, to exclusively commercialize and distribute Akantior (polihexanide) in 26 countries within the European Economic Area and Switzerland. Under the terms of the agreement,
- Johnson & Johnson Vision Reveals New Data on Blue-Violet Light Filtering Technology in Acuvue Oasys Max 1-Day Contact Lenseshttps://modernod.com/news/johnson-johnson-vision-reveals-new-data-on-blue-violet-light-filtering-technology-in-acuvue-oasys-max-1-day-contact-lenses/2481196/Johnson & Johnson Vision Care will present new data on the positive effects of wearing blue-violet light filtering contact lenses at the 2022 American Academy of Optometry (AAO) annual meeting in San Diego, October 26-29. "As a result of our increasingly digital
- J&J Vision Presents New Data on Myopia, IOLs, Phacoemulsification, Dry Eye Drops, Vision Science and Refractive Technologieshttps://modernod.com/news/jj-vision-presents-new-data-on-myopia-iols-phacoemulsification-dry-eye-drops-vision-science-and-refractive-technologies-at-arvo/2480839/Johnson & Johnson Vision is presenting 26 poster and podium presentations focusing on myopia, cataract, dry eye, vision science, and refractive research at the Association for Research in Vision and Ophthalmology (ARVO) 2022 Live and Virtual Annual Meeting. Johnson & Johnson Vision poster
- Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2022 ASCRShttps://modernod.com/news/glaukos-technologies-featured-in-numerous-scientific-abstracts-at-the-2022-ascrs/2480788/Glaukos announced that its technologies will be featured in various scientific programming at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, being held April 22–26, 2022 in Washington, DC. In addition, Glaukos is sponsoring an educational symposium
- J&J Vision Presents Data Validating Improved Surgical Outcomes and Surgeon Satisfaction at ASCRShttps://modernod.com/news/johnson-johnson-vision-presents-data-validating-improved-surgical-outcomes-and-surgeon-satisfaction-across-cataract-and-refractive-portfolio-at-ascrs/2480787/Johnson & Johnson Vision will present and/or support 46 company-sponsored and investigator-led studies evaluating innovations and outcomes across its surgical portfolio at the 2022 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting in Washington, DC, April 22-26.
- Alcon Announces Scientific Program at ASCRS 2022https://modernod.com/news/alcon-announces-scientific-program-at-ascrs-2022/2480782/Alcon will once again have a significant scientific presence at the American Society of Cataract and Refractive Surgery (ASCRS) 2022 annual meeting, taking place April 22-26 in Washington, DC. Approximately 150 abstracts feature Alcon’s leading ophthalmic products and equipment—with m
- Allergan to Present New Data from its Eye Care Portfolio at ASCRS 2022https://modernod.com/news/allergan-to-present-new-data-from-its-eye-care-portfolio-at-ascrs-2022/2480778/Allergan announced that it will present new data from its eye care portfolio at the 2022 ASCRS annual meeting being held April 22–26 in Washington, DC. Presentations will include new data on Vuity (pilocarpine HCl ophthalmic solution) 1.25%, the first and only
- Oyster Point Pharma to Present New Clinical Data at ASCRS 2022https://modernod.com/news/oyster-point-pharma-to-present-new-clinical-data-at-ascrs-2022/2480775/Oyster Point Pharma announced the presentation of data analyses at the American Society of Cataract and Refractive Surgery (ASCRS), being held on April 22-26. The company-sponsored clinical trials that will be presented highlight the recently approved Tyrvaya (varenicline solution)
- Bausch + Lomb Will Present New Scientific Data During the ASCRS Annual Meetinghttps://modernod.com/news/bausch-lomb-will-present-new-scientific-data-during-the-ascrs-annual-meeting/2480769/Bausch + Lomb announced the presentation of 10 podium presentations and two poster presentations during the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, which will take place from April 22-26, 2022 in Washington, DC. The presentations will i
- Orasis Pharmaceuticals to Present New Data on Novel Presbyopia Candidate at ASCRShttps://modernod.com/news/orasis-pharmaceuticals-to-present-new-data-on-novel-presbyopia-candidate-at-ascrs/2480764/Orasis Pharmaceuticals announced that it will present new data on its novel eye drop candidate, CSF-1, at the 2022 American Society for Cataract and Refractive Surgery (ASCRS) annual meeting being held April 22-26 in Washington, D.C. "We look forward to these present